Market Currents
The FDA orders Johnson & Johnson (JNJ), C.R. Bard (BCR), Endo Pharmaceuticals (ENDP), and...
-
Wednesday, January 4, 2012, 3:29 PM ETThe FDA orders Johnson & Johnson (JNJ), C.R. Bard (BCR), Endo Pharmaceuticals (ENDP), and Boston Scientific (BSX) to study medical damage caused by vaginal implants. The request follows a July report of a fivefold jump in deaths, injuries, or malfunctions related to the devices.
Other date
Latest Consumer Articles
